Centrex, Inc. Featured in Latest Issue of BIOMOLECULAR DIAGNOSTICS NEWS.Business Editors/Health/Medical Writers TULSA, Okla.--(BUSINESS WIRE)--July 22, 2003 Centrex, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CNEX) today announced that it has recently been featured in an article in BIOMOLECULAR DIAGNOSTICS NEWS. The article discusses Centrex's development agreement with Micronics, Inc. and the application of microfluidics technology to single molecule nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. detection. Centrex had recently announced the signing of a development agreement with Redmond, Washington-based Micronics, Inc. to design and develop disposable, multipurpose mul·ti·pur·pose adj. Designed or used for several purposes: a multipurpose room; multipurpose software. multipurpose Adjective microfluidics lab cards that incorporate Centrex's single molecule nucleic acid detection ("SMD (1) (Storage Module Device) A high-performance hard disk interface used with minis and mainframes that transfers data in the 1-4 MBytes/sec range (SMD-E provides highest rate). See hard disk. ") technology. BIOMOLECULAR DIAGNOSTICS NEWS is a publication that tracks developments at the cutting edge of molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller and nanotechnology with respect to molecular diagnostics. It reports on new and innovative technologies, giving analytical insights into the evolving biomolecular diagnostics industry. The publication, edited by Steven A. Edwards, is produced by a skilled team of seasoned industry and technology analysts who provide essential information for business and industry. BIOMOLECULAR DIAGNOSTICS NEWS is published by BCC (Blind Carbon Copy) The field in an e-mail header that names additional recipients for the message. It is similar to carbon copy (cc), but the names do not appear in the recipient's message. Not all e-mail systems support the bcc feature. See fcc. , Inc., based in Norwalk, Connecticut. Additional information or subscriptions may be obtained by calling (203) 853-4266 or sending a fax to (203) 853-0348. Centrex's SMD technology has been exclusively licensed from Los Alamos National Laboratories and represents advantages over existing DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. and RNA RNA: see nucleic acid. RNA in full ribonucleic acid One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic detection methods as well as culture-based test methods. The technology eliminates the need for amplification of the target DNA, which reduces the possibility of false positive and negative test results - common concerns identified with other test procedures. Centrex's detection system is designed to be adaptable to the detection of a variety of bacterial or viral organisms by recognizing the unique DNA or RNA fingerprint of the organism. Centrex plans to focus on the commercialization of a first product that provides a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. Potential additional applications for the Centrex technology include bioterrorism and Homeland Security Noun 1. Homeland Security - the federal department that administers all matters relating to homeland security Department of Homeland Security executive department - a federal department in the executive branch of the government of the United States , food and water processing, blood supply screening, and general DNA/RNA testing. About Micronics Micronics, Inc. offers full service custom lab card development and integrated instrumentation on behalf of clients worldwide. Micronics has both an established microfluidics-based patent portfolio and extensive experience in providing essential "microplumbing" of fluids to on card micro-electrical-mechanical (MEMS (MicroElectroMechanical Systems) Tiny mechanical devices that are built onto semiconductor chips and are measured in micrometers. In the research labs since the 1980s, MEMS devices began to materialize as commercial products in the mid-1990s. ) devices, sensors, adsorbents, lateral flow strips, reagents, and membranes. Micronics can also embed glass, silicon, and other features on card. Micronics provides lab card prototyping as well as commercial lab card production services. For additional information, visit www.micronics.net. This press release contains certain forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in the Company's SEC filings. For more information, visit the Centrex website at www.centrexcorporation.com or contact Loren Brown at 407-682-2001. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion